Clal Biotechnology reported ILS-6.17M in Net Income for its fiscal quarter ending in December of 2022.





Net Income Change Date
aTyr Pharma USD -25.74M 6.21M Sep/2025
Clal Biotechnology ILS -6.17M 15.56M Dec/2022
Compugen USD -6.98M 360K Sep/2025
RedHill Biopharma USD -1.54M 0 Jun/2024